Back
Citius Oncology, Inc. 10K Form
Sell
20
CTOR
Citius Oncology, Inc.
Last Price:
$1.11
Seasonality Move:
0.9%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CTOR News And Ratings
See the #1 stock for the next 7 days that we like better than CTOR
CTOR Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.45 |
| Price / Book: | 2.69 |
Profitability
| EPS (TTM): | -0.28000 |
|---|---|
| Net Income (TTM): | $-24M |
| Gross Margin: | $0 |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Citius Oncology, Inc. Earnings Forecast
Key Citius Oncology, Inc. Financial Ratios
-
Per Share Earnings over the last 4 years have been positive in 2 years.
Citius Oncology, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | CTOR |
Debt
| Debt-to-Equity Ratio: | 0.12 |
|---|---|
| Current Ratio: | 0.35 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
CTOR Technical Analysis vs Fundamental Analysis
Sell
20
Citius Oncology, Inc. (CTOR)
is a Sell
Is Citius Oncology, Inc. a Buy or a Sell?
-
Citius Oncology, Inc. stock is rated a SellThe current Citius Oncology, Inc. [CTOR] share price is $1.11. The Score for CTOR is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.